Maternal and fetal consequences of preeclampsia

Internet Journal of Gynecology and Obstetrics

Volumn 13, Issue 1, 2010, Pages

  Nwosu, Zeribe Chike ^a   Omabe, Maxwell ^b  

^a EBONYI STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

eclampsia; HELLP syndrome; IUGR; Placenta; Preeclampsia; sFlt 1

Indexed keywords

ARGININE; LOSARTAN;

CHILDBIRTH; DEVELOPED COUNTRY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ECLAMPSIA; EDEMA; FAMILY HISTORY; FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; HYPOVOLEMIC SHOCK; INTRAUTERINE GROWTH RETARDATION; MATERNAL CARE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MULTIPARA; NEWBORN MORBIDITY; NEWBORN MORTALITY; OBESITY; OLIGOHYDRAMNIOS; PATIENT MONITORING; PREECLAMPSIA; PREGNANCY; PRENATAL CARE; PRIMIGRAVIDA; PROTEINURIA; RENOVASCULAR DISEASE; REVIEW; RISK ASSESSMENT; SURVIVAL RATE;

EID: 77954188674     PISSN: None     EISSN: 15288439     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. ACOG Committee on Obstetric Practice. ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynaecol 2002; 99:159-167
2. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet. 2001;357:53-56.
3. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008;51:970-975
4. Baker PN, (Ed). Obstretics by Ten Teachers. 18th Edition, London, Arnold, 2006. pp 42-46, 158-170
5. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683.
6. Lam C, Lim K, and Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005;46:1077-1085
7. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 1998;179:1359-1375.
8. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285:1607-1612
9. Staun-Ram E and Shaley E: Human trophoblast function during implantation process. Reprod Biol Endocrinol 2005; 3:56
10. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy- induced hypertension. J Clin Endocrinol Metab. 2003;88:2393-2398.
11. Kaaja, RJ and Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005;294:2751-2757
12. Paulson RJ, Boostanfar R, Saadat P, Mor E, Tourgeman DE, Slater CC, Francis MM, Jain JK, Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age. JAMA 2002;288:2320-2323
13. Bryan SM and Hindmarsh PC. Normal and abnormal fetal growth. Horm Res 2006; 65:19-27
14. Alexander BT. Prenatal influences and endothelial dysfunction a link between reduced placental perfusion and preeclampsia. Hypertension 2007;49:775-776 (Editorial)
15. Robertson WB, Uteroplacental vasculature. J. Clin. Pathol. 1976, 29: 9-17
16. Song C, Song JC, Han J, Narayanan S: Preeclampsia-eclampsia: pathogenesis, diagnosis and treatment. Available from: http://www.uspharmacist.com/index.asp?show=article&page=8_949.htm (Accessed on 15/08/2007)
17. Roberts DJ and Post MD, The placenta in preeclampsia and IUGR. J. Clin. Pathol. published online 19 Jul 2008 [doi:10.1136/jcp.2008.055236].
18. Zamorski MA and Green LA, Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy: A Summary for Family Physicians. Am Fam Physician 2001; 64:263-270
19. Hergit A, Berkane N, Lefevre G, Toumi K, Marti H, Capeau J, Uzan S, Rondeau E. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 2004; 50:1702-1703
20. Barbieri RL and Repke JT. Medical Disorders During Pregnancy. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Jameson JL (Eds): Harrison's Principles of Internal Medicine. 16th edition, USA, McGraw-Hill, 2005 pp 32-33
21. Cohen A, Lim KH, Lee Y. Angiogenic markers in preeclampsia and preexisting diabetes. Diabetes 2007;30:375-377
22. Zhou CC, Ahmad S, Mi T, Abbasi S, Xia L, Day M, Ramin SM, Ahmed A, Kellems RE, and Xia Y. Autoantibody from women with preeclampsia induces soluble fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 2008;51;1010-1019
23. Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW. Uric acid is an important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005; 46: 1263-1269
24. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, and Karumanchi SA. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992-1005.
25. Duckitt K and Harrington D. Risk Factors for Preeclampsia at Antenatal Booking: Systematic Review of Controlled Studies. BMJ 2005; 330: 565
26. Xia Y, Ramin SM, Kellems RE. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 2007;50;269-275
27. Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician 2004;70: 2317-2324
28. Gamzu R, Rotstein R, Fusman R, Zeltser D, Berliner AS, and Kupferminc MJ. Increased erythrocyte adhesiveness and aggregation in peripheral venous blood of women with pregnancy-induced hypertension. Obstet Gynecol 2001: 98: 307-312
29. Stalker AL. Fibrin deposition in pregnancy. J. Clin. Path., 1976, 29: s70-76
30. Vikse BE, Irgens LM, Leivestad T, Skjarven R, and Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008;359:800-809
31. Germain AM, Romanik MC, Guerra I, Solari S, Reyes MA, Johnson RJ, Price K, Karumanchi SA, Valde ́s G. Endothelial dysfunction a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 2007;49;90-95
32. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005; 105:402-410
33. Govan ADT. The histology of eclamptic lesions. J. Clin. Pathol. 1976; 29;63-69
34. Wolf JL. Liver disease in pregnancy. Med Clin North Am 1996; 80: 1167-1187
35. Padden, MO. HELLP syndrome: recognition and perinatal management. Am Fam Physician 60: 829-839
36. Kumar V and Maitra A. Disease of Infancy and Childhood. In: Kumar V, Abbas AK, Fausto N: Robbins and Cotran Pathologic Basis of Disease. 7th edition, Philadelphia, Elsevier, 2005. pp 469-508
37. Ounsted M and Ounsted C. Maternal regulation of intra-uterine growth. Nature 1966, 212:995-999
38. Morin I, Morin L, Zhang X, Platt RW, Blondel B, Breart G, Usher R, and Kramer MS. Determinants and consequences of discrepancies in menstrual and ultrasonographic gestational age estimates. BJOG 2005; 112:145-152
39. Taipale P and Hiilesmaa V Predicting delivery date by ultrasound and last menstrual period in early gestation. Obstet Gynecol 2001; 97:189-194
40. Greer IA. Preeclampsia Matters - New guideline is simple, evidence based, and clinical, and should be used. BMJ 2005; 330: 549-550